🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Etoposide-cisplatin/ -carboplatin in combination with PD-L1 inhibitor for 4...
Status
Completed
Location
Hunan cancer hospital
Start Date
2020-06-01
Trial ID
NCT04636762
Treatments Being Tested
This study is a prospective, randomized, single-center randomized controlle...
Status
Recruiting
Location
First Affiliated Hospital of Wenzhou Medical University
Start Date
2026-04-30
Trial ID
NCT07381634
Treatments Being Tested
This is a single arm phase II study assessing the activity of atezolizumab ...
Status
Terminated
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2018-12-19
Trial ID
NCT03737123
Treatments Being Tested
The purpose of this study is to determine whether cytoreduction of bulky me...
Status
Withdrawn
Location
The University of Kansas Medical Center
Start Date
2024-07-15
Trial ID
NCT06416436
Treatments Being Tested
This is a phase II trial of neoadjuvant and adjuvant atezolizumab with or w...
Status
Active Not Recruiting
Location
University of California San Diego Moores Cancer Center
Start Date
2023-12-07
Trial ID
NCT05798663
Treatments Being Tested
This study is expected to enroll 182 patients with partial response or stab...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-16
Trial ID
NCT06719336
The purpose of this study is to evaluate the efficacy and safety of atezoli...
Status
Completed
Location
Stanford University
Start Date
2020-08-24
Trial ID
NCT04513925
Treatments Being Tested
Locoregional failure remains the principal mode of mortality in head and ne...
Status
Completed
Location
Froedtert & Medical College of Wisconsin
Start Date
2021-01-26
Trial ID
NCT04477759
This study includes the additional use of radiation therapy in combination ...
Status
Completed
Location
WVU Cancer Institute - Mary Babb Randolph Cancer Center
Start Date
2017-01-23
Trial ID
NCT03035890
Treatments Being Tested
This phase II trial studies how well image guided hypofractionated radiatio...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2017-06-09
Trial ID
NCT03050060